Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
about
Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example.Gene signatures of breast cancer progression and metastasis.Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer.Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.Metabolic syndrome and pre-diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways.The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.Validation of analytical breast cancer microarray analysis in medical laboratory.Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy.Gene network inherent in genomic big data improves the accuracy of prognostic prediction for cancer patients.Statin Use and Breast Cancer Prognosis in Black and White Women.
P2860
Q31052319-8ECE2240-4F33-48FC-8622-2C171338B782Q35029477-21FC385E-37D0-4A5F-B219-B3CB1473D732Q36261762-BE8F6D3D-D2F9-4E85-AD8B-3D274B393025Q37160326-09E07115-4802-437B-8569-3B032E920746Q37191427-0FC269CE-9A16-46C3-926D-99FA3FA9DC26Q38747402-085E56D7-4276-4468-BC72-F8D36C5BA23FQ38962113-DEE61353-E613-4965-B2E9-6DA9F12A23F2Q43516120-B7B510AD-B47C-4A1D-B5C8-ACAF5CAD3810Q45983567-C9F34D3B-96AD-496B-AC58-AF126D2CEF65Q47755766-2BF64273-043F-43F6-BED1-231E44912B34
P2860
Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Benefits of biomarker selectio ...... reast cancer prognostic models
@ast
Benefits of biomarker selectio ...... reast cancer prognostic models
@en
Benefits of biomarker selectio ...... reast cancer prognostic models
@nl
type
label
Benefits of biomarker selectio ...... reast cancer prognostic models
@ast
Benefits of biomarker selectio ...... reast cancer prognostic models
@en
Benefits of biomarker selectio ...... reast cancer prognostic models
@nl
prefLabel
Benefits of biomarker selectio ...... reast cancer prognostic models
@ast
Benefits of biomarker selectio ...... reast cancer prognostic models
@en
Benefits of biomarker selectio ...... reast cancer prognostic models
@nl
P2093
P2860
P356
P1476
Benefits of biomarker selectio ...... reast cancer prognostic models
@en
P2093
Ana M Gonzalez
David L Rimm
Fabio Parisi
Harriet M Kluger
Robert L Camp
Yasmine Nadler
Yuval Kluger
P2860
P2888
P356
10.1186/BCR2633
P577
2010-09-01T00:00:00Z
P5875
P6179
1000691010